JP2013525338A5 - - Google Patents

Download PDF

Info

Publication number
JP2013525338A5
JP2013525338A5 JP2013505534A JP2013505534A JP2013525338A5 JP 2013525338 A5 JP2013525338 A5 JP 2013525338A5 JP 2013505534 A JP2013505534 A JP 2013505534A JP 2013505534 A JP2013505534 A JP 2013505534A JP 2013525338 A5 JP2013525338 A5 JP 2013525338A5
Authority
JP
Japan
Prior art keywords
active
ingredient
fluticasone
active pharmaceutical
propionate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013505534A
Other languages
English (en)
Japanese (ja)
Other versions
JP6347608B2 (ja
JP2013525338A (ja
Filing date
Publication date
Priority claimed from PT105058A external-priority patent/PT105058B/pt
Application filed filed Critical
Publication of JP2013525338A publication Critical patent/JP2013525338A/ja
Publication of JP2013525338A5 publication Critical patent/JP2013525338A5/ja
Application granted granted Critical
Publication of JP6347608B2 publication Critical patent/JP6347608B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013505534A 2010-04-21 2011-04-21 医薬品有効成分の粒子加工のための方法 Active JP6347608B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT105058 2010-04-21
PT105058A PT105058B (pt) 2010-04-21 2010-04-21 Processo para processamento de partículas de ingredientes activos farmacêuticos
PCT/GB2011/000631 WO2011131947A2 (en) 2010-04-21 2011-04-21 A process for particle processing of active pharmaceutical ingredients

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016176303A Division JP6857467B2 (ja) 2010-04-21 2016-09-09 医薬品有効成分の粒子加工のための方法

Publications (3)

Publication Number Publication Date
JP2013525338A JP2013525338A (ja) 2013-06-20
JP2013525338A5 true JP2013525338A5 (enExample) 2013-11-07
JP6347608B2 JP6347608B2 (ja) 2018-06-27

Family

ID=44194836

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013505534A Active JP6347608B2 (ja) 2010-04-21 2011-04-21 医薬品有効成分の粒子加工のための方法
JP2016176303A Active JP6857467B2 (ja) 2010-04-21 2016-09-09 医薬品有効成分の粒子加工のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016176303A Active JP6857467B2 (ja) 2010-04-21 2016-09-09 医薬品有効成分の粒子加工のための方法

Country Status (13)

Country Link
US (1) US9956144B2 (enExample)
EP (1) EP2560620B1 (enExample)
JP (2) JP6347608B2 (enExample)
CN (1) CN102970978B (enExample)
BR (1) BR112012026941A2 (enExample)
CA (1) CA2796978C (enExample)
IL (1) IL222596B (enExample)
MX (1) MX338594B (enExample)
PL (1) PL2560620T3 (enExample)
PT (1) PT105058B (enExample)
RU (1) RU2597790C2 (enExample)
SG (1) SG185003A1 (enExample)
WO (1) WO2011131947A2 (enExample)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691145B2 (en) 2009-11-16 2014-04-08 Flodesign Sonics, Inc. Ultrasound and acoustophoresis for water purification
EP3689364A1 (en) 2010-02-08 2020-08-05 Shenzhen Evergreen Therapeutics Co., Ltd. Methods for the use of progestogen as a glucocorticoid sensitizer
US10987361B2 (en) 2010-02-08 2021-04-27 Shenzhen Evergreen Therapeutics Co., Ltd. Treating auto-immune and auto-inflammatory diseases
US10993879B2 (en) 2010-02-08 2021-05-04 Shenzhen Evergreen Therapeutics Co., Ltd. Pulmonary delivery of progestogen
US9421553B2 (en) 2010-08-23 2016-08-23 Flodesign Sonics, Inc. High-volume fast separation of multi-phase components in fluid suspensions
US9752113B2 (en) 2012-03-15 2017-09-05 Flodesign Sonics, Inc. Acoustic perfusion devices
US9783775B2 (en) 2012-03-15 2017-10-10 Flodesign Sonics, Inc. Bioreactor using acoustic standing waves
US10370635B2 (en) 2012-03-15 2019-08-06 Flodesign Sonics, Inc. Acoustic separation of T cells
US9688958B2 (en) 2012-03-15 2017-06-27 Flodesign Sonics, Inc. Acoustic bioreactor processes
US9796956B2 (en) 2013-11-06 2017-10-24 Flodesign Sonics, Inc. Multi-stage acoustophoresis device
US10322949B2 (en) 2012-03-15 2019-06-18 Flodesign Sonics, Inc. Transducer and reflector configurations for an acoustophoretic device
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
US9567559B2 (en) 2012-03-15 2017-02-14 Flodesign Sonics, Inc. Bioreactor using acoustic standing waves
US9752114B2 (en) 2012-03-15 2017-09-05 Flodesign Sonics, Inc Bioreactor using acoustic standing waves
US10689609B2 (en) 2012-03-15 2020-06-23 Flodesign Sonics, Inc. Acoustic bioreactor processes
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US9745548B2 (en) 2012-03-15 2017-08-29 Flodesign Sonics, Inc. Acoustic perfusion devices
US10967298B2 (en) 2012-03-15 2021-04-06 Flodesign Sonics, Inc. Driver and control for variable impedence load
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
US9272234B2 (en) 2012-03-15 2016-03-01 Flodesign Sonics, Inc. Separation of multi-component fluid through ultrasonic acoustophoresis
PT106237B (pt) * 2012-03-30 2015-03-19 Hovione Farmaci Ncia S A Produção de partículas substancialmente monodispersas utilizando moagem e separação por membranas
US11324873B2 (en) 2012-04-20 2022-05-10 Flodesign Sonics, Inc. Acoustic blood separation processes and devices
US10737953B2 (en) 2012-04-20 2020-08-11 Flodesign Sonics, Inc. Acoustophoretic method for use in bioreactors
PT106738B (pt) * 2013-01-09 2015-06-08 Hovione Farmaciencia Sa Método para o controlo do fenómeno de degradação difusional de ostwald (ostwald ripening) no processamento de partículas de um ingrediente farmacêutico
SG11201508804QA (en) * 2013-04-25 2015-11-27 Flodesign Sonics Inc Excipient removal from pharmacological samples
US9745569B2 (en) 2013-09-13 2017-08-29 Flodesign Sonics, Inc. System for generating high concentration factors for low cell density suspensions
EP3738592B1 (en) 2013-10-08 2022-01-26 AI Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
CA2935960C (en) 2014-01-08 2023-01-10 Bart Lipkens Acoustophoresis device with dual acoustophoretic chamber
PT107433B (pt) * 2014-01-28 2018-12-04 Hovione Farm S A Processo de redução e controlo do tamanho de partícula
MX2016010373A (es) 2014-02-11 2016-11-30 Lam Therapeutics Inc Rapamicina para el tratamiento de linfangioleiomiomatosis.
US10307371B2 (en) 2014-02-11 2019-06-04 AI Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
PT107567B (pt) * 2014-03-31 2019-02-13 Hovione Farm S A Secador por atomização com atomizador múltiplo, método para o aumento de escala de pós para inalação secos por dispositivo de atomização múltiplo e uso de vários atomizadores num secador por atomização
BR112016022598A8 (pt) 2014-04-04 2021-06-29 Ai Therapeutics Inc composição aerossol farmacêutica na forma de um pó seco para liberação pulmonar, forma de dosagem unitária, pacote farmacêutico, kit e uso
US9744483B2 (en) 2014-07-02 2017-08-29 Flodesign Sonics, Inc. Large scale acoustic separation device
RU2732908C2 (ru) 2014-10-07 2020-09-24 ЭйАй ТЕРАПЬЮТИКС, ИНК. Ингаляционная лекарственная форма рапамицина для лечения легочной гипертензии
MA40910A (fr) 2014-11-07 2017-09-12 Civitas Therapeutics Inc Poudres de rapamycine pour administration pulmonaire
WO2016130645A1 (en) 2015-02-10 2016-08-18 Lam Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
US10106770B2 (en) 2015-03-24 2018-10-23 Flodesign Sonics, Inc. Methods and apparatus for particle aggregation using acoustic standing waves
PT108368B (pt) 2015-03-31 2018-11-05 Hovione Farm S A Produção contínua de partículas
US11021699B2 (en) 2015-04-29 2021-06-01 FioDesign Sonics, Inc. Separation using angled acoustic waves
CA2984492A1 (en) 2015-04-29 2016-11-03 Flodesign Sonics, Inc. Acoustophoretic device for angled wave particle deflection
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
EP3297740A1 (en) 2015-05-20 2018-03-28 Flodesign Sonics Inc. Acoustic manipulation of particles in standing wave fields
US10161926B2 (en) 2015-06-11 2018-12-25 Flodesign Sonics, Inc. Acoustic methods for separation of cells and pathogens
WO2016205334A1 (en) 2015-06-16 2016-12-22 Vascular Strategies Llc Drug delivery and imaging chemical conjugate, formulations and methods of use thereof
CA2995043C (en) 2015-07-09 2023-11-21 Bart Lipkens Non-planar and non-symmetrical piezoelectric crystals and reflectors
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
PT109030B (pt) 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
US10710006B2 (en) 2016-04-25 2020-07-14 Flodesign Sonics, Inc. Piezoelectric transducer for generation of an acoustic standing wave
EP3481361A1 (en) 2016-05-03 2019-05-15 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
JP2020513248A (ja) 2016-10-19 2020-05-14 フロデザイン ソニックス， インク．Ｆｌｏｄｅｓｉｇｎ Ｓｏｎｉｃｓ， Ｉｎｃ． 音響による親和性細胞抽出
KR20220066413A (ko) 2017-12-14 2022-05-24 프로디자인 소닉스, 인크. 음향 트랜스듀서 구동기 및 제어기
IL309073A (en) 2021-06-03 2024-02-01 Arcadia Medicine Inc Enantiomeric entactogen compounds and methods of their use.
JP2025522774A (ja) 2022-07-04 2025-07-17 ホビオネ サイエンティア リミテッド 吸入用被覆結晶形態乾燥粉末の乾燥粉末吸入器用医薬組成物
WO2025064867A1 (en) * 2023-09-21 2025-03-27 Yuva Biosciences, Inc. Delivery system for mitochondrial health enhancers

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19875032I2 (de) 1990-09-10 2007-04-19 Schering Corp Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
US6184765B1 (en) * 1999-01-07 2001-02-06 Nec Research Institute, Inc. Switch useful at superconducting temperatures and comprising superconducting material
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
GB0125604D0 (en) * 2001-10-25 2001-12-19 Glaxo Group Ltd Novel process
JP4684545B2 (ja) 2002-09-26 2011-05-18 大日本住友製薬株式会社 溶出性の良好なイソキサゾール誘導体経口製剤
ES2566486T3 (es) 2004-03-31 2016-04-13 Toyama Chemical Co., Ltd. Dispersión fina de fármaco moderadamente soluble y proceso de producción de la misma
EP1595534A1 (en) * 2004-05-13 2005-11-16 Universiteit Utrecht Holding B.V. Gel composition comprising charged polymers
EP1828100A1 (en) * 2004-12-17 2007-09-05 Cipla Ltd. Pharmaceutical compounds and compositions
CN101102740A (zh) * 2005-01-07 2008-01-09 卫材R&D管理有限公司 药用组合物以及其制备方法
US20060193818A1 (en) * 2005-02-25 2006-08-31 Southall Michael D Compositions containing amines and use thereof
DE102005011786A1 (de) 2005-03-11 2006-09-14 Pharmasol Gmbh Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
GB0523576D0 (en) 2005-11-18 2005-12-28 Theradeas Ltd Drug composition and its use in therapy
US20070178051A1 (en) 2006-01-27 2007-08-02 Elan Pharma International, Ltd. Sterilized nanoparticulate glucocorticosteroid formulations
EP2170279B1 (en) * 2007-07-31 2017-12-27 Otsuka Pharmaceutical Co., Ltd. Methods for producing aripiprazole suspension and freeze-dried formulation
EP2050437A1 (en) 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
EP2156823A1 (en) * 2008-08-14 2010-02-24 Pharmatex Italia Srl Process for the preparation of sterile powdered pharmeceutical compounds in the form of micro and nanoparticles

Similar Documents

Publication Publication Date Title
JP2013525338A5 (enExample)
JP2017019845A5 (enExample)
US9956144B2 (en) Process for particle processing of active pharmaceutical ingredients
US20130319411A1 (en) Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
JP2018199684A (ja) Ｒ（＋）ブデソニド及び１以上の気管支拡張剤を含む医薬組成物
AU2008334547B2 (en) Organic compounds
CN105120841B (zh) 抗毒蕈碱化合物的粒度减小
MXPA05006441A (es) Preparacion de suspensiones acuosas esteriles que comprenden ingredientes activos cristalinos micronizados para inhalacion.
JP2019501876A5 (enExample)
KR20100099281A (ko) 유기 화합물
US20150352077A1 (en) Multi-Component Crystalline Particles for Inhalation Therapy
CN103347518A (zh) 含有抗毒蕈碱药物的无推进剂液体制剂
JP6653323B2 (ja) 吸入可能な製剤
ES2831019T3 (es) Un procedimiento para el procesamiento de partículas de ingredientes farmacéuticos activos
HK1216302B (zh) 抗毒蕈硷化合物的粒度减小